Articles nAture methods | VOL.9 NO.10 | OCTOBER 2012 | 993 malaria afflicts over 200 million people worldwide, and its most lethal etiologic agent, Plasmodium falciparum, is evolving to resist even the latest-generation therapeutics. efficient tools for genome-directed investigations of P. falciparum-induced pathogenesis, including drug-resistance mechanisms, are clearly required. here we report rapid and targeted genetic engineering of this parasite using zinc-finger nucleases (ZFns) that produce a double-strand break in a user-defined locus and trigger homology-directed repair. targeting an integrated egfp locus, we obtained gene-deletion parasites with unprecedented speed (2 weeks), both with and without direct selection. ZFns engineered against the parasite gene pfcrt, responsible for escape under chloroquine treatment, rapidly produced parasites that carried either an allelic replacement or a panel of specified point mutations. this method will enable a diverse array of genome-editing approaches to interrogate this human pathogen.
using attB × attP integrase-mediated recombination 12 , generating the NF54 EGFP line that was uniformly EGFP positive ( Fig.  1b-d) . We then designed a composite pZFN egfp -egfp-human dihydrofolate reductase (hdhfr) donor plasmid comprising our 2A-linked egfp-specific ZFN expression cassette as well as two homology regions (egfp 5′ and 3′) that flanked the ZFN cleavage site. To select for egfp-disrupted parasites, the 5′ homology region was fused in frame with hdhfr 13 such that resistance to the antifolate drug WR99210 would be contingent on the egfp-hdhfr fusion integrating downstream of the genomic calmodulin promoter (Fig. 1b) . Targeted integration of hdhfr into the egfp locus should produce a GFP-negative parasite.
After electroporation of the ZFN donor plasmid into the NF54 EGFP line, parasites were selected directly with WR99210 (yielding the NF54 ∆egfpA line) or first supplemented with red blood cells preloaded with plasmid DNA (reported to increase transformation efficiency 14 and yielding the three lines NF54 ∆egfp-B1/B2/B3 ). With all four lines, WR99210-resistant parasites were detected 15 d after electroporation. We confirmed ZFN-driven disruption of the egfp gene by fluorescence microscopy, PCR and Southern blotting ( Fig. 1c-e) . Flow cytometry of the bulk cultures revealed the complete loss of fluorescence in all NF54 ∆egfp lines (Fig. 1f) . Three independent transfections with a ZFN-deficient control pegfp-hdhfr plasmid failed to yield parasites after 60 d.
To assess potential off-target activity of the ZFNs, we sequenced the genomes of two edited lines (NF54 ∆egfpA and NF54 ∆egpfB1 ) as well as the parent (NF54 EGFP ). Sequence analysis revealed a depth of coverage of hdhfr (56× and 42× for NF54 ∆egfpA and NF54 ∆egfpB1 , respectively) that mirrored the average coverage across the entire genome (54× and 69×), consistent with the presence of a single genomic copy of hdhfr (Supplementary Table 1) . Furthermore, flanking sequence reads that partially overlapped hdhfr could only be mapped to the egfp-hdhfr locus, consistent with the specific disruption of egfp ( Supplementary Fig. 1a,b) .
Gene replacement in the absence of a selectable phenotype
Gene disruption by in-frame integration of a selectable marker is limited to targets that are expressed during the asexual blood stage.
We sought to develop a broader strategy for gene manipulation, irrespective of expression pattern during the parasite life cycle and independent of a selection event. We first aimed to replace the egfp reporter with monomeric rfp (mrfp) fused to the cytosolic ATPase pfvps4. This fusion was placed on a donor plasmid (pmrfp-vps4) flanked by egfp UTRs and plasmid backbone sequences (3.5 kb and 2.8 kb on the 5′ and 3′ ends, respectively) that provided templates for homologous recombination (Fig. 2a) . ZFNs were expressed from a separate plasmid (pZFN egfp -hdhfr) containing the hdhfr selectable marker. The plasmids were coelectroporated, and WR99210 pressure was applied for 6 d to transiently enrich for parasites that expressed the ZFNs. Parasite proliferation was detected microscopically 12 d after electroporation.
Imaging and quantification of parasite fluorescence from the bulk cultures was consistent with a gene replacement efficiency of 88% and 62% in two independent experiments (Fig. 2b,c) . This level of efficiency was confirmed by analysis of clonal lines, which expressed mRFP and not EGFP in 19 of 27 (70%) and 21 of 39 (54%) cloned parasites from the two experiments. This recombination event involves DNA end resection of greater than 260 bp from at least one side of the DSB, leading to invasion of the mrfp flanking sequences common to both the donor plasmid and the chromosomal egfp locus (Fig. 2a) . These flanking sequences were shared with the ZFN expression vector, which could compete with the pmrfp-vps4 plasmid as a template for homology-directed repair and could account for the minority of nonfluorescent parasites observed in the bulk cultures (Fig. 2c) . PCR and Southern blot analyses nonetheless confirmed replacement of egfp with the mrfp fusion in the majority of parasites, shown in two representative clones (Fig. 2d,e) .
Allelic replacement of an endogenous parasite gene
An important drug-resistance determinant in P. falciparum is the chloroquine (CQ) resistance transporter PfCRT 15, 16 . The extensive worldwide use of CQ in malaria treatment has led to the selection of multiple mutations in pfcrt 17 . Genetic engineering of isogenic parasites expressing various pfcrt alleles is required to fully analyze their phenotypic impact on drug response, but this has proven exceptionally time and labor intensive 18, 19 . 
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We designed ZFNs against pfcrt using an archive of prevalidated modules, each consisting of two zinc fingers 8, 20 . On the basis of results from yeast proxy cleavage assays 21 (data not shown), we selected the two most active nuclease pairs (13/15 and 14/15; Supplementary Table 2) . These pairs, which target the boundary of intron 1 and exon 2, were cloned into a plasmid expressing a blasticidin S-deaminase (bsd) selectable marker, thereby yielding pZFN crt -bsd (Fig. 3a) . The pfcrt donor sequence was inserted on a second plasmid (pcrt Dd2 -hdhfr), consisting of the pfcrt cDNA from the CQ-resistant (CQR) strain Dd2 and the 3′ UTR from the P. berghei crt ortholog, followed by an hdhfr expression cassette that served as an independent selectable marker. Upstream and downstream regions of homology flanked these elements to promote ZFN-mediated replacement of the entire 3.1-kb gene with the donor-provided pfcrt 1.2 kb-cDNA and the downstream hdhfr selectable marker (Fig. 3a) .
We chose to modify the CQ-sensitive (CQS) strains 106/1 and GC03, which harbor distinct alleles and exhibit characteristic drug-response phenotypes 15 . We first electroporated the donor plasmid pcrt Dd2 -hdhfr and applied WR99210 to select for episomally transformed parasites (Fig. 3a) . These parasites were then electroporated with pZFN crt -bsd, and blasticidin was applied for 6 d to enable transient ZFN expression and consequent homologydirected repair. Prolonged selection for the ZFN plasmid (12 d) caused a delay in parasite re-emergence after electroporation (data not shown), potentially due to repeated chromosome cleavage. After removal of blasticidin, but not WR99210, parasite proliferation was detected microscopically after 13-16 d. In a clonal analysis, we observed replacement events in 13 of 82 (15.9%) 106/1 clones and 4 of 83 (4.8%) GC03 clones by PCR (Fig. 3b) . Southern blotting of two representative clones (GC03 crt-Dd2 G9 and GC03 crt-Dd2 H6 ) demonstrated acquisition of the donor-provided CQR pfcrt allele (Fig. 3c) . We confirmed the CQ resistance phenotype of these two clones, which both displayed a four-to fivefold shift in CQ half-maximal inhibitory concentration (IC 50 ) values compared to the GC03 parent (Fig. 3d) . Notably, in three independent transfections, 106/1 and GC03 parasites that only received the pfcrt donor plasmid but not the ZFN plasmid failed to yield allelic replacement parasites after more than 6 months.
site-specific editing of a parasite drug-resistance locus We next assessed whether our engineered pfcrt-targeted ZFNs could drive a subtle gene-editing event that delivers a single point mutation to the targeted site from an episomal donor template. In contrast, conventional allelic exchange strategies for P. falciparum typically result in significant modification of the endogenous locus by crossover-mediated incorporation of the entire plasmid (often as a concatamer), including a selectable marker and other sequence elements 3 .
To achieve gene editing in P. falciparum, we exploited the CQ resistance-conferring properties of mutant pfcrt. PfCRT mediates resistance by transporting CQ from the digestive vacuole when residue Lys76 has mutated to threonine (in the case of field isolates) or isoleucine (observed in CQ-pressured 106/1 parasites 15, 22, 23 ). pfcrt alleles from CQR parasite strains also possess at least three additional, potentially compensatory mutations 24 . For this experiment, we chose the CQS 106/1 strain, whose pfcrt allele encodes six out of seven CQR mutations observed in Asian and African strains while retaining the CQS Lys76 codon (Fig. 4a) . On the basis of prior studies 15, 22 , mutation of pfcrt codon 76 from lysine to isoleucine in this isolate was predicted to confer resistance.
We generated the ZFN expression plasmid pZFN crt -bsd with a 1-kb pfcrt donor sequence that spans the ZFN cleavage site and encodes the K76I mutation (yielding the plasmid pZFN crt -76I) (Fig. 4a) . We tested two versions of the donor sequence: one with an intact ZFN binding site ('mut1') and another with four silent mutations ('mut2'). The latter was designed to prevent ZFN binding In five independent parasite transfections, we observed 100% K76I conversion rates by sequence analysis of the pfcrt locus ( Fig. 4a and Table 1 ). No alternate mutations were detected at this position. Editing of the Lys76 codon was equally successful using either ZFN pair (13/15 or 14/15; Supplementary Table 2) , irrespective of whether the ZFN binding site was mutated in the donor construct ( Table 1) . Of note, the additional four silent mutations in the mut2 template were always incorporated at the pfcrt locus. In addition, both the mut1 and mut2 donor templates contained a pfcrt 5′ UTR sequence harboring a single-base-pair deletion (a string of seven thymidines (T 7 ), compared to eight (T 8 ) in the endogenous locus). This deletion, located ~300 bp upstream of the ZFN cut site, was transferred into the edited gene sequence with a mean efficiency of 51% ( Table 1) . By comparison, mutations located an equivalent distance from the nuclease cleavage site have been captured with considerably lower frequency in mammalian cells (for example, 5% in mouse embryonic stems cells 25 ). Importantly, the T 7 deletion was captured despite its presence on the side opposite the DSB relative to the selected K76I mutation (located 140 bp downstream of the ZFN cleavage site). The incorporation into the chromosomal target of all mutations on the donor plasmid could be explained by gene editing proceeding via synthesis-dependent strand annealing or other noncrossover events (Fig. 4a and Supplementary Fig. 2 ) 10 .
We confirmed the CQ-resistance phenotype of two gene-edited lines, 106/1 13/15mut2 and 106/1 14/15mut1 (Fig. 4b) . Both lines displayed a five-to sixfold shift in CQ IC 50 values relative to the 106/1 parental strain. This shift in drug response was comparable to a CQR mutant of 106/1 (termed 106/1 I76 ) bearing the K76I mutation derived by CQ pressure 15, 22 .
Whole-genome sequencing revealed no detectable off-target activity of the pfcrt-targeting ZFN pairs in two representative recombinant lines (106/1 13/15mut1 and 106/1 14/15mut1 ). Illumina next-generation sequencing yielded a 15× coverage for >97% of all three genomes (Supplementary Table 1 ). We found no evidence of any rearrangement of the pfcrt locus in these edited lines, and we confirmed 100% incorporation of the K76I mutation (Supplementary Fig. 1c) .
To demonstrate the applicability of ZFNs for generating single-nucleotide polymorphisms (SNPs) that may not confer a selectable phenotype, we repeated the ZFN-mediated pfcrt K76I editing event described above without applying CQ pressure. To select for transfected parasites and ensure ZFN expression, we added the hdhfr selection cassette to the mut2 version of the pZFN crt -76I plasmid (yielding pZFN crt -76I-hdhfr) (Fig. 4a) . Transfected Dd2 parasites were selected with WR99210 for 6 d, and parasite proliferation was observed 11 d after removal of drug. From two independent experiments, we generated a total of 76 clones and used these to PCRamplify the pfcrt genomic locus ( Table 1) . This analysis identified the ZFN binding-site mutations in 18.4% and the K76I mutation in 15.8% of clones. The upstream T 7 deletion was also found in all edited clones. These data suggest that nonselected gene-editing events can be generated efficiently enough to readily permit the isolation of modified parasite clones by limiting dilution, thus expanding the range of potential targets beyond those related to drug resistance. npg discussion Here we have established diverse ZFN-driven strategies with broad utility for interrogating the P. falciparum genome. These include gene disruption and replacement approaches that can be used to verify the essentiality of parasite genes as well as sitespecific editing approaches to probe gene function. ZFN-mediated genome editing of P. falciparum differs fundamentally from prior methods of genetic manipulation, which have typically relied on stochastic integration of plasmids designed for gene disruption or allelic exchange via homologous recombination ( Supplementary  Fig. 2 ) 26 . In these cases, integration likely takes place after a rare and random DSB occurs in the gene of interest. Plasmid integration is typically observed after 2-4 months, and any fitness costs resulting from genome manipulation jeopardize the acquisition of the recombinant line. Extreme cases include the engineering of the pfcrt CQ-resistance locus, which required two rounds of genetic manipulation and over 18 months of continuous culture to obtain the desired clones 18 . Furthermore, the nondirected nature of this earlier method of allelic exchange meant that integration could take place at any genomic site with homology to the transfection plasmid, often yielding undesired outcomes. Even if integration occurs in the desired locus, single-site crossovers could result in a recombinant locus that harbors the plasmidborne mutations in a nonfunctional duplicated fragment and not the functional gene 27 . With the approaches we describe, parasites carrying the desired specific editing event can be obtained rapidly and with an efficiency that approaches 100% in cases when the outcome yields a selectable phenotype. Notably, we could readily obtain parasites with gene-deletion, allelic-exchange or single-nucleotide editing events even in the absence of a selectable phenotype. The efficiencies of these editing events ranged from relatively high in the case of the egfp-mrfp replacement (88%), when ~3-kb homology arms were provided on either side of the target locus, to more modest levels (~18% efficiency) for the pfcrt K76I editing, when a 1-kb sequence was used as the donor template. These editing efficiencies Figure 4 . a Only lines identified as edited at the binding site were analyzed with a second sequencing reaction for the T (deletion).
npg were sufficient to readily isolate parasite clones bearing the desired modifications. Furthermore, the capture of mutations several hundred base pairs from the DSB site provides some flexibility when selecting ZFN pairs. The shortest region of homology was 0.5 kb (for the egfp disruption strategy), and the potential increase in editing efficiency by using longer regions must be balanced by constraints on the size and stability in E. coli of AT-rich P. falciparum transfection plasmids. ZFN-mediated editing can now be leveraged to generate knockouts or more subtle modifications (including fusions with fluorescent reporters 20 or affinity tags) that probe parasite gene function across a broad range of biological contexts. This includes the ability to inactivate genes without integrating a selectable marker, thus fulfilling an important requirement for genetically attenuated vaccines. ZFNs can also be deployed for sequencespecific editing 28 -for example, to assess the involvement of candidate loci and identify causal polymorphisms in order to survey the spread of antimalarial drug resistance in endemic areas. ZFN-mediated genome editing now adds a powerful reversegenomic methodology for dissecting the etiologic agent of a major human infectious disease.
methods
Methods and any associated references are available in the online version of the paper.
Requests for materials.
Requests for ZFNs should be directed to furnov@sangamo.com. online methods Zinc-finger nuclease engineering. ZFNs specific for egfp have been described previously 29 . ZFNs targeting pfcrt (MAL7P1.27) were designed and assembled using an archive of validated modules 8 and screened for activity using a yeast proxy system 21 .
Plasmid construction. To test whether the Thosea asigna virus 2A peptide 11 could mediate cotranslational polypeptide separation in P. falciparum, we generated the pDC2-cam-mrfp-2A-gfp-attP plasmid (whose expression cassette is illustrated in Fig. 1a) . The 2A and mrfp fragments were first amplified separately and linked by 'splicing by overlap extension' (SOE) PCR. The 2A sequence was amplified from the plasmid pVAX-ZFN-L-2A-ZFN-R 21 using primers p18 + p19 (Supplementary Table 3) , and mrfp was amplified from pML2 (ref. 30) using primers p21 + p22. The linked mrfp-2A sequence was amplified using primer p21 and either p19 (full 2A sequence) or p20 (2A∆P21). Finally, the mrfp-2A fusions were digested with AvrII and BglII and inserted into a pDC2-based expression vector 30 following excision of the 5′ gfp full-length sequence in the tandem gfp-gfp plasmid pDC2-camgfp(N-C)-attP. To generate the construct used to produce the NF54 EGFP line, the egfp coding sequence was amplified from an EGFP-FokI plasmid using primers p23 + p24 and was cloned into the AvrII and XhoI restriction sites of pDC2-cam-gfp(N-C)-attP. This cloning yielded the egfp integration plasmid pDC2-camegfp-attP used to generate the NF54 EGFP line.
Expression of ZFNs in P. falciparum was achieved by cloning these downstream of a calmodulin (PF14_0323) promoter and upstream of an hsp86 (PF07_0030) 3′ UTR in a pDC2 vector with or without the hdhfr or bsd selectable marker. ZFNs linked with the 2A peptide were digested with NheI and XhoI and were cloned into the compatible restriction sites AvrII and XhoI, thereby yielding the intermediate plasmids pZFN egfp and pZFN crt and the final transfection plasmids pZFN egfp -hdhfr and pZFN crt -bsd. The donor templates provided for the ZFN-induced DSB repair were either placed on the same plasmid as the ZFN expression cassette or on a separate plasmid, as indicated below.
To generate the egfp-hdhfr donor template (Fig. 1b) , we first amplified 5′ and 3′ regions of homology flanking the ZFN cleavage site in the integrated egfp locus. The 5′ region was PCR-amplified from pDC2-cam-egfp-attP using primers p3 + p25 (yielding a 543-bp product), whereas the 3′ region (denoted egfp 3′) was amplified using primers p27 + p28 (yielding a 795-bp product). A promoterless hdhfr selection cassette was then amplified with primers p26 + p4 and fused in frame to egfp 5′ using primers p3 + p4 in a SOE PCR reaction. The egfp-hdhfr template was then cloned into pZFN egfp using ApaI and SacII restriction sites. The second homologous region egfp 3′ was then inserted using the restriction sites BstAPI and ZraI, thereby yielding the transfection plasmid pZFN egfp -egfp-hdhfr (Fig. 1b) . To produce the pegfp-hdhfr control plasmid, we excised the egfp-specific ZFN segment following HindIII digestion of pZFN egfp -egfphdhfr and agarose gel electrophoresis, and then we religated the plasmid.
To assemble the mrfp-vps4 donor template (Fig. 2a) , we amplified mrfp and vps4 separately and then linked the two products by SOE PCR. The mrfp sequence was amplified from pML2 (ref. 30) using primers p29 + p30, and vps4 was amplified from NF54 genomic DNA using primers p31 + p32. The linked mrfp-vps4 sequence was amplified with p29 + p32 and cloned into the AvrII and XhoI restriction sites of pDC2, thereby yielding the replacement plasmid pmrfp-vps4.
To generate the pcrt Dd2 -hdhfr donor plasmid for pfcrt allelic replacement (Fig. 3a) , we first amplified intron 1 through exon 13 of pfcrt Dd2 cDNA and pbcrt 3′ UTR from an expression plasmid 31 using p33 + p34. The PCR product was cloned into the restriction sites NotI and SpeI of the pCC1 plasmid (containing an hdhfr cassette). The left homology region, comprising the pfcrt 5′ UTR to intron 1 sequence (431 bp), was subcloned from the pZFN crt -76I plasmid with ApaI and SalI (see below). The pfcrt 3′ UTR served as the right region of homology and was amplified from 106/1 gDNA using primers p35 + p36 (yielding a 1,050-bp product) and then inserted into EcoRI and ClaI to generate the allelic replacement plasmid pcrt Dd2 -hdhfr (Fig. 3a) .
We generated two donor constructs to introduce a single point mutation (K76I) in pfcrt, located 140 bp downstream of the ZFN cut site. A 1-kb donor fragment without additional mutations at the ZFN target site (mut1) was PCR-amplified from genomic DNA isolated from 106/1 I76 parasites 15 using primers p37 + p38 and was cloned into the ApaI and SacI restriction sites in pZFN crt . We also generated a second donor template with four silent mutations at the ZFN binding site (mut2) via SOE PCR using primers p37 + p39 and p38 + p40 for the first round of PCR and p37 + p38 for the second round (Supplementary Table 3 ). The same restrictions sites ApaI and SacI were used to clone donor fragment mut2. Both donor constructs contained a single-nucleotide (T) deletion in the 5′ UTR of pfcrt located 0.3 kb upstream of the ZFN cut site. The two ZFN pairs (13/15 and 14/15; Supplementary Table 2) were expressed from a plasmid (pZFN crt -76I) containing either the mut1 or mut2 donor. with 2.5 nM WR99210 the following day. All phenotypic and genotypic analyses of this set of parasite lines were performed on bulk cultures.
To perform our ZFN-driven egfp replacement with mrfp, we coelectroporated NF54 EGFP parasites with the plasmids pZFN egfphdhfr and pmrfp-vps4 (Fig. 2a) . The pZFN egfp -hdhfr plasmid contained the 2A-linked egfp-specific ZFNs that were expressed from a calmodulin promoter. Selection for this plasmid was applied with 2.5 nM WR99210, which was applied 1 d post-electroporation and was maintained for 6 d. The pmrfp-vps4 plasmid provided the mrfp donor sequence flanked by homologous regions. No selection was applied for this plasmid. Parasite clones illustrated in Figure 2 were generated by limiting dilution.
To replace the endogenous pfcrt allele, GC03 and 106/1 parasites were first electroporated with the donor plasmid pcrt Dd2 -hdhfr and selected with 2.5 nM WR99210 to enrich for episomally transformed parasites. These parasites (GCO3 + pcrt Dd2 -hdhfr or 106/1 + pcrt Dd2 -hdhfr) were then electroporated with pZFN crt -bsd (Fig. 3a) . One day after electroporation, parasites were selected with 2 µg/ml blasticidin (Invitrogen) and 2.5 nM WR99210 for 6 d and then selected with only WR99210. Parasite clones were generated by limiting dilution where indicated.
To edit pfcrt using CQ selection, 106/1 parasites were electroporated with pZFN crt -76I plasmids harboring either the mut1 or mut2 sequence template (the latter harbored four ZFN binding site mutations). Transformed parasites were treated with 33 nM CQ phosphate (Sigma-Aldrich) to select for acquisition of the K76I mutation (Fig. 4a) . To edit pfcrt without CQ selection, Dd2 parasites were electroporated with pZFN crt -76I-hdhfr. One day after electroporation, parasites were exposed to 2.5 nM WR99210 for 6 d to select for plasmid transformation (Fig. 4a) . Analysis of parasite lines was performed on bulk cultures. DNA analysis. P. falciparum trophozoite-infected erythrocytes were harvested and saponin-lysed. Parasite genomic DNA was extracted and purified using DNeasy Blood kits (Qiagen). Integration of the hdhfr cassette into the cg6-egfp locus of NF54 EGFP parasites was confirmed by PCR amplification of the target locus using primers p1 + p2 (yielding a 1.8-kb fragment), p1 + p4 (3.9 kb), p5 + p7 (4.2 kb) and p3 + p6 (1.5 kb in NF54 EGFP and 3.4 kb in ZFN-transfected parasites) (Fig. 1b,d) . Replacement of the integrated egfp with mrfp at the chromosomal cg6 locus was shown by PCR amplification of the target locus using primers p10 + p7 (yielding a 5.7-kb fragment), p1 + p9 (yielding a 4.8-kb fragment) and p8 + p6 (yielding a 2.8-kb fragment for the mrfp-vps4 replacement, compared with 1.6 kb for the original egfp locus and 3.3 kb for the zfn cassette) (Fig. 2a,d) .
Allelic replacement of the endogenous GC03 pfcrt locus by the pcrt Dd2 -hdhfr donor sequence was confirmed by PCR of the target locus with primers p11 + p13 (GC03 parent: 1.4 kb, GC03 crt-Dd2 recombinant: 1.2 kb, GC03 + pcrt Dd2 -hdhfr: 1.4 kb, pcrt Dd2 -hdhfr: no product); p12 + p13 (GC03: 0.6 kb, GC03 crt-Dd2 : 0.4 kb, GC03 + pcrt Dd2 -hdhfr: 0.4 and 0.6 kb, pcrt Dd2 -hdhfr: 0.4 kb); and p14 + p15 (GC03: no product, GC03 crt-Dd2 : 2.5 kb, GC03 + pcrt Dd2 -hdhfr: no product, pcrt Dd2 -hdhfr: no product) (Fig. 3a,c) .
Editing of pfcrt codon 76 (Fig. 4) was confirmed by PCRamplifying the genomic locus with primers p23 + p27 that flank the pfcrt donor sequence. These products were amplified either from bulk cultures (and afterward cloned into pGEM-T), or from parasite clones ( Table 1) . Sequencing was performed with primers p24, p25, p26, p18 and p20 (Supplementary Table 3 ).
Whole-genome sequencing and data processing. Genomic DNA was prepared from the parental line NF54 EGFP and the two ZFNtransfected lines NF54 ∆egfpA and NF54 ∆egfpB1 as well as from 106/1 and 106/1 13/15mut1 and 106/1 14/15 mut1 . These DNAs were sheared (10 µg per line) to obtain a fragment size of ~200-400 bp using an E220 focused-ultrasonicator (Covaris Inc.) and the following settings: 10% duty cycle, intensity 5, 200 cycles per burst, 180 s treatment time. Sheared gDNA was size selected on a 2% low-melting agarose gel and then purified. Barcoded libraries for Illumina TruSeq single-end sequencing were then constructed from the size-selected, sheared material using NEBNext DNA Library Preparation reagents (NEB) by following the standard Illumina library preparation protocol but omitting the final size-selection step. To assess the quality and percentage of adaptor-ligated material, the final sequencing libraries were tested on an Agilent 2100 Bioanalyzer (Agilent Technologies) along with the original size-selected fragmented gDNA from the same preparation. The concentration of each library was determined using a Quant-iT dsDNA Broad-Range Assay Kit (Invitrogen). For the NF54 ∆egfpB1 line, the sequencing adaptor ligation was determined to be less than 50% efficient. We therefore PCR-amplified the sequencing library as described 33 to minimize GC bias. PCR conditions for 50-µl reactions were: 1× Kapa HiFi Buffer, 60 nM tetramethylammonium chloride, 0.3 mM each dNTP, 0.4 µM each primer and 1 U Kapa HiFi DNA polymerase, with thermocycling conditions of 1 min at 98 °C followed by 12 cycles of 10 s at 98 °C, 1 min at 55 °C and finally 5 min at 55 °C. The final libraries were multiplexed with three barcoded samples and 20% PhiX control DNA per lane and were sequenced using an Illumina HiSeq 2000 system. Sequencing outputs were uploaded into Galaxy 34 , which is hosted locally at the Lewis-Sigler Institute for Integrative Genomics at Princeton University. Sequence reads were mapped to the P. falciparum 3D7 reference genome v. 8.0 (http://plasmodb.org/ common/downloads/release-8.0/Pfalciparum/) using the BurrowsWheeler alignment tool 35 , and files were formatted using Sequence Alignment/Maptools 36 . GATK tools were applied to assess depths of coverage for the overall genomes and specific regions of interest and to perform SNP discovery and filtering using standard hardfiltering parameters 37 . Alignments and variants were visualized using the Integrative Genomics Viewer 38 .
Southern blot hybridizations. Edited lines obtained from the egfp disruption and the egfp/mrfp replacement experiments and the parental control were analyzed using pairs of Southern blots, as follows. For each blot, 2 µg of genomic DNA was digested with ClaI + BamHI, separated by electrophoresis on a 0.7% agarose gel and transferred onto a Nytran nylon membrane. Hybridization of the first blot was performed at 54 °C with a 710-bp 32 P-labeled egfp probe that was PCR-amplified from pDC2-cam-egfp-attP using primers p3 + p26. The second blot was either hybridized with a 560-bp 32 P-labeled hdhfr probe or a 670-bp 32 P-labeled mrfp probe amplified by PCR with primers p10 + p17 (mrfp) or p28 + p4 (hdhfr) from the respective plasmids pmrfp-vps4 or pZFN egfp -hdhfr. Linearized transfection plasmids served as positive controls (8.4 kb, 8.3 kb and 9.9 kb for the egfp, mrfp and hdhfr experiment, respectively; see Figs. 1e and 2e) .
npg
Parasite lines obtained following pfcrt allelic replacement were analyzed on pairs of Southern blots, for which 2 µg of genomic DNA was digested with SalI + BstBI. Digests were separated by electrophoresis on a 0.7% agarose gel and transferred onto a Nytran nylon membrane. Hybridization was performed at 55 °C with a 600-bp 32 P-labeled hdhfr probe amplified from pcrt Dd2 -hdhfr by PCR with primers p26 + p4.
In vitro susceptibility assays. In vitro IC 50 values were determined by incubating parasites for 72 h across a range of concentrations of CQ (2,000 nM −2.5 nM). After 72 h of incubation, parasite growth was determined by measuring parasitemia using flow cytometry. Cells were stained with 1.6 µM Mito Tracker Deep Red and 2× SYBR Green (Invitrogen) in 1× PBS supplemented with 5% FBS 39 . In vitro IC 50 values were calculated by nonlinear regression analysis and Mann-Whitney U tests were used for statistical analysis. A nonparametric statistical analysis was appropriate as experiments were independent and no normal distribution was assumed.
For the pfcrt gene-replacement experiment (Fig. 3d) , the IC 50 value for the GC03 parental line (mean ± s.e.m. 18.4 ± 5.3 nM, n = 4) was significantly different from the two pfcrt allelic replacement clones GC03 crt-Dd2 G9 (91.8 ± 10.7 nM, n = 4, P = 0.028, two-tailed) and GC03 crt-Dd2 H6 (100.3 ± 15.5 nM, n = 4, P = 0.028, two-tailed). No significant difference in IC 50 values was observed between the parental GCO3 line and the control GC03 + pcrt Dd2 -hdhfr line that episomally replicated the donor plasmid (18.6 ± 6.8 nM, n = 4, P = 1.0, two-tailed).
For the pfcrt gene-editing experiment (Fig. 4b) , the IC 50 value for the 106/1 parental line (mean ± s.e.m. 27.4 ± 1.2 nM, n = 4) was significantly different (*P = 0.028, two-tailed, Mann-Whitney U test) from the gene-edited parasites 106/1 13/15mut2 (153.6 ± 18.3 nM) and 106/1 14/15mut1 (145.1 ± 17.8 nM) as well as the previously established CQR line 106/1 I76 (177.9 ± 16.8 nM).
Fluorescence analysis of recombinant parasites. For live-cell imaging, resuspended cultures were washed once with RPMI-1640 media lacking Albumax II, and the cells were applied to poly(l-lysine)-coated glass-bottom culture dishes (MatTek) and overlaid with 1 ml of RPMI media containing 2 µg/ml Hoechst 33342 (Sigma) to stain the nuclei. Images were acquired on a Nikon Ti-E inverted microscope with 100× N.A. 1.4 PlanApo optics and a CoolSnap HQ2 camera. Images were collected with Nikon NIS Elements software and assembled using Adobe Photoshop.
To quantify the proportion of EGFP-positive parasites in the NF54 EGFP and ZFN-modified lines, parasite cultures were analyzed by flow cytometry. Cells were stained for 10 min with 250 nM SYTO 61 dye (Invitrogen) in aqueous solution containing 0.2% dextrose and 0.9% sodium chloride. After a single wash, 50,000 cells were counted on an Accuri C6 Flow Cytometer. Data were analyzed with FlowJo 7.6.3 with gating for nuclear stain SYTO 61 (FL4) and for green fluorescence (FL1).
